Besides its protective role against amyloid-β (Aβ) deposition in AD [86], ApoE2 is linked to reduced regional tau in all brain regions, while ApoE4 is associated with greater regional tau, mainly in the medial temporal lobe [87]. This evidence concerns the gene MAPT and Alzheimer disease.